No | Method | Medium | Application | Linear range | Reference |
---|---|---|---|---|---|
1 | HPLC | Phosphate buffer: acetonitrile (65:35) | Tablets | 20 to 100 μg/mL | Raju and Rao 2011 |
2 | HPLC | Phosphate buffer: acetonitrile: Tetrahydrofuran (60:40:0.1) | Tablets (combination with amlodipine) | 10 to 100 μg/mL | Zaazaa et al. 2013 |
3 | HPLC | Phosphate buffer: acetonitrile (55:45) | Tablets (combination with amlodipine) | 16 to 96 μg/mL | Riyaz et al. 2012 |
4 | HPLC | Acetonitrile: acidic water (50:50) | Tablets (combination with losartan potassium) | 1 to 30 μg/mL | Chaudhary et al. 2010 |
5 | HPLC | Phosphate buffer: acetonitrile (75:25) | Dosage forms (combination with indapamide) | 24 to 56 μg/mL | Jogia et al. 2010 |
6 | HPLC | Phosphate buffer: acetonitrile (60:40) | Dosage forms (combination with indapamide) | 8 to 24 μg/mL | Joseph et al. (2011) |
7 | HPLC | Phosphate buffer: acetonitrile (65:35) | Tablets (combination with amlodipine) | 8 to 60 μg/mL | Prajapati et al. 2011a |
8 | LC-MS/MS | - | Human plasma | 0.5 to 350 ng/mL | Jaina et al. 2006 |
9 | LC/MS | - | Human plasma | 0.1 to 100 ng/mL | Nirogi et al. [2006] |
10 | HPTLC | Dichloromethane: methanol: glacial acetic acid (9.5:0.5:0.1) | Dosage forms (combination with indapamide) | 1 to 5 μg/band | Dewani et al. 2011 |
11 | Spectrophotometry | Chloroform | Tablets | 5 to 125 μg/mL | Neelam et al. 2012 |
12 | Spectrophotometry | Dimethylsulfoxide | Tablets | 2.5 to 25 μg/mL | Rahman et al. 2012 |
13 | Spectrophotometry | Methanol | Tablets (combination with amlodipine) | 4 to 12 μg/mL | Prajapati et al. 2011b |
14 | Spectrofluorimetry | Dichloromethane | Tablets | 1 to 21 μg/mL | This work |